IL17A and myeloid sarcoma: Among diverse CD4+ T-cell subsets, interleukin-17 (IL-17)-positive Th17 cells, which secrete IL-17A, are regarded as the primary effector cells in provoking an inflammatory response in MS/EAE (4).